chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test negative, Tremor
Clinical narrative: Shortness of breath, low oxygen level, dyspnea, elevated HR, increased bruising.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Contusion, Dyspnoea, Fibrin D dimer, Full blood count
Clinical narrative: Shortness of breath, low oxygen level, dyspnea, elevated HR, increased bruising.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Oxygen saturation decreased, SARS-CoV-2 test
Clinical narrative: Shortness of breath, low oxygen level, dyspnea, elevated HR, increased bruising.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Embolic stroke, Mechanical ventilation, Mental status changes
Clinical narrative: Pt received a dose of Janssen roughly 3 months after receiving a dose of Pfizer in January. We never received documentation (electronic or paper copy) of the previous COVID vaccine or information from family prior to the DOH administering the Janssen vaccine to the patient on 4/5/2021. The patient was asked if she wanted the COVID vaccine on 4/2/2021. She appeared of sound mind at the time, and also was listed as Responsible Party in her facesheet. The patient received the Janssen vaccine on 4/5/2021, prior to us later that day being made aware by her daughter that she had previously received a Pfizer dose several months ago. I personally was informed of her prior Pfizer dose on 4/9/2021 when the daughter came to visit. At that time I immediately called the CDC and spoke to an individual on the vaccination line. I informed them of the event and asked what type of event this was considered. Due to this being day 4 post administration, they said it was deemed a non-adverse event vaccination error. We completed a Risk Management form and the family was also made aware. On 4/10/2021 the patient went to the hospital for decreased oxygen reads, and was eventually diagnosed with aspiration pneumonia and subsequent hypovolemic shock due to her other comorbidities including new acute CVA and right common femoral DVT proximal/distal/ and medial. Per the hospital documentation the doctor said that he did not feel that it was related to the Janssen vaccine.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram, Deep vein thrombosis, Extra dose administered, Hypovolaemic shock
Clinical narrative: Pt received a dose of Janssen roughly 3 months after receiving a dose of Pfizer in January. We never received documentation (electronic or paper copy) of the previous COVID vaccine or information from family prior to the DOH administering the Janssen vaccine to the patient on 4/5/2021. The patient was asked if she wanted the COVID vaccine on 4/2/2021. She appeared of sound mind at the time, and also was listed as Responsible Party in her facesheet. The patient received the Janssen vaccine on 4/5/2021, prior to us later that day being made aware by her daughter that she had previously received a Pfizer dose several months ago. I personally was informed of her prior Pfizer dose on 4/9/2021 when the daughter came to visit. At that time I immediately called the CDC and spoke to an individual on the vaccination line. I informed them of the event and asked what type of event this was considered. Due to this being day 4 post administration, they said it was deemed a non-adverse event vaccination error. We completed a Risk Management form and the family was also made aware. On 4/10/2021 the patient went to the hospital for decreased oxygen reads, and was eventually diagnosed with aspiration pneumonia and subsequent hypovolemic shock due to her other comorbidities including new acute CVA and right common femoral DVT proximal/distal/ and medial. Per the hospital documentation the doctor said that he did not feel that it was related to the Janssen vaccine.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, Magnetic resonance imaging head abnormal, Oxygen saturation decreased, Pneumonia aspiration, Ultrasound Doppler abnormal
Clinical narrative: Pt received a dose of Janssen roughly 3 months after receiving a dose of Pfizer in January. We never received documentation (electronic or paper copy) of the previous COVID vaccine or information from family prior to the DOH administering the Janssen vaccine to the patient on 4/5/2021. The patient was asked if she wanted the COVID vaccine on 4/2/2021. She appeared of sound mind at the time, and also was listed as Responsible Party in her facesheet. The patient received the Janssen vaccine on 4/5/2021, prior to us later that day being made aware by her daughter that she had previously received a Pfizer dose several months ago. I personally was informed of her prior Pfizer dose on 4/9/2021 when the daughter came to visit. At that time I immediately called the CDC and spoke to an individual on the vaccination line. I informed them of the event and asked what type of event this was considered. Due to this being day 4 post administration, they said it was deemed a non-adverse event vaccination error. We completed a Risk Management form and the family was also made aware. On 4/10/2021 the patient went to the hospital for decreased oxygen reads, and was eventually diagnosed with aspiration pneumonia and subsequent hypovolemic shock due to her other comorbidities including new acute CVA and right common femoral DVT proximal/distal/ and medial. Per the hospital documentation the doctor said that he did not feel that it was related to the Janssen vaccine.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Arteriogram carotid normal, Blood creatine phosphokinase, Blood glucose normal, Blood magnesium
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood phosphorus, Blood thyroid stimulating hormone, Cerebral atrophy, Cerebral infarction, Cerebral small vessel ischaemic disease
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray, Computerised tomogram head abnormal, Computerised tomogram neck, Dehydration, Differential white blood cell count
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diplopia, Dizziness, Echocardiogram, Electrocardiogram, Full blood count
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glycosylated haemoglobin, Lipase, Lipids, Low density lipoprotein normal, Magnetic resonance imaging head abnormal
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic function test, Ophthalmological examination normal, Red blood cell sedimentation rate, Scan with contrast abnormal, Subarachnoid haemorrhage
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin I, Urine analysis, Vertigo, Vision blurred, Visual impairment
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: White matter lesion
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood glucose normal, Cerebral infarction, Cerebral ischaemia, Computerised tomogram normal, Dehydration
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diplopia, Dizziness, Glycosylated haemoglobin normal, Low density lipoprotein normal, Magnetic resonance imaging abnormal
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Subarachnoid haemorrhage, Vertigo, Vision blurred, Visual impairment, White matter lesion
Clinical narrative: Per the family: on Monday, February 15 he experienced visual disturbances with slightly blurred vision. Not thinking anything of it at the time, the vision cleared, and he continued about their evening/week without telling anyone of his visual disturbances. On Sunday, February 21, he experienced additional visual disturbances including double vision and dizziness, and we had him visit a local ER for evaluation. He was discharged with a diagnosis of dehydration and vertigo. No scans were performed. The visual disturbances cleared up the following week and the only persistent symptom was a slight dizziness. An eye exam was performed on Friday, February 26 with no problems found. An MRI was performed on March 3, and he was diagnosed with the below conditions.   Impression (3/3/2021) 1. Small acute to subacute infarcts in the left splenium of the corpus callosum and parasagittal left occipital lobe. 2. Trace subarachnoid hemorrhage in the parasagittal left parietal lobe. 3. Mild chronic microvascular ischemic disease. He was admitted to the hospital and remained there until Saturday, March 6. Follow-up scans and testing were performed with no underlying reason for the stroke being determined. Prior to the stroke, he had been a very active individual with osteoarthritis as is only health complaint. He was not on any prescription medication prior to the stroke. While in the hospital, the tests for high blood pressure, high cholesterol (LDL 92 MG/DL), sugar inadequacies (glucose 93 mg/dl, A1C 5.7%), etc. came back without major concerns. His follow-up CT scans also did not reveal the stroke shown on the MRI. No inquiry was made by any of his doctors or hospital staff as to his COVID vaccination status/dates to even consider the connection. Below are the results of the last CT scans:  Impression (3/4/2021) 1. Age-related volume loss and white matter disease similar to prior exams. 2. Small infarct seen on MRI are not well seen on CT. 3. No acute intracranial abnormality demonstrated on the CT scan.  Impression (3/5/2021) 1. No evidence of acute infarct or intracranial hemorrhage. No significant change. 2. Periventricular white matter disease is likely secondary to chronic small vessel ischemic changes. Per daughter on 4/23/21 patient has improved significantly
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Pyrexia, Vomiting
Clinical narrative: CHEST PAIN; STOMACH PAIN; VOMITING; DIZZY; SWEATING; CHILLS; FEVER; This spontaneous report received from a parent concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced chest pain. On 10-APR-2021, the subject experienced stomach pain. On 10-APR-2021, the subject experienced vomiting. On 10-APR-2021, the subject experienced dizzy. On 10-APR-2021, the subject experienced sweating. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 11-APR-2021, had not recovered from stomach pain, and dizzy, and the outcome of vomiting, chest pain and sweating was not reported. This report was non-serious.; Sender's Comments: v0-Medical assessment comment not required as case is assessed as per standard operating procedures.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chest pain, Chills, Dizziness, Hyperhidrosis
Clinical narrative: CHEST PAIN; STOMACH PAIN; VOMITING; DIZZY; SWEATING; CHILLS; FEVER; This spontaneous report received from a parent concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced chest pain. On 10-APR-2021, the subject experienced stomach pain. On 10-APR-2021, the subject experienced vomiting. On 10-APR-2021, the subject experienced dizzy. On 10-APR-2021, the subject experienced sweating. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 11-APR-2021, had not recovered from stomach pain, and dizzy, and the outcome of vomiting, chest pain and sweating was not reported. This report was non-serious.; Sender's Comments: v0-Medical assessment comment not required as case is assessed as per standard operating procedures.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: CHEST PAIN; STOMACH PAIN; VOMITING; DIZZY; SWEATING; CHILLS; FEVER; This spontaneous report received from a parent concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced chest pain. On 10-APR-2021, the subject experienced stomach pain. On 10-APR-2021, the subject experienced vomiting. On 10-APR-2021, the subject experienced dizzy. On 10-APR-2021, the subject experienced sweating. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 11-APR-2021, had not recovered from stomach pain, and dizzy, and the outcome of vomiting, chest pain and sweating was not reported. This report was non-serious.; Sender's Comments: v0-Medical assessment comment not required as case is assessed as per standard operating procedures.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Fatigue, Pain, Pain in extremity, Syncope
Clinical narrative: BLOOD CLOT IN LEFT LUNG; This spontaneous report received from a consumer concerned a female of unspecified age (in late 40's or early 50's) and ethnicity unspecified. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was diagnosed with blood clot in her left lung after receiving the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This female patient of unspecified ethnicity, in her late 40's or realy 50's, was reported to have blood clot in h er lungs after an unspecified duration from receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection.  No other details was reported.  Based on the information that is available, the event is assessed as indeterminate with the causal association to immunization, per WHO causality classification of adverse events following immunization based on a lack of a definitive plausible biological mechanism.  However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded.  Additional information will be requested once contact information is obtained
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Antiphospholipid antibodies, Arthralgia, Asthenia, Beta-2 glycoprotein antibody
Clinical narrative: BLOOD CLOT IN LEFT LUNG; This spontaneous report received from a consumer concerned a female of unspecified age (in late 40's or early 50's) and ethnicity unspecified. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was diagnosed with blood clot in her left lung after receiving the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This female patient of unspecified ethnicity, in her late 40's or realy 50's, was reported to have blood clot in h er lungs after an unspecified duration from receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection.  No other details was reported.  Based on the information that is available, the event is assessed as indeterminate with the causal association to immunization, per WHO causality classification of adverse events following immunization based on a lack of a definitive plausible biological mechanism.  However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded.  Additional information will be requested once contact information is obtained
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Blood test, Computerised tomogram, Discomfort, Fatigue
Clinical narrative: BLOOD CLOT IN LEFT LUNG; This spontaneous report received from a consumer concerned a female of unspecified age (in late 40's or early 50's) and ethnicity unspecified. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was diagnosed with blood clot in her left lung after receiving the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This female patient of unspecified ethnicity, in her late 40's or realy 50's, was reported to have blood clot in h er lungs after an unspecified duration from receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection.  No other details was reported.  Based on the information that is available, the event is assessed as indeterminate with the causal association to immunization, per WHO causality classification of adverse events following immunization based on a lack of a definitive plausible biological mechanism.  However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded.  Additional information will be requested once contact information is obtained
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fibrin D dimer, Headache, Heart rate, Hypertension, Loss of consciousness
Clinical narrative: BLOOD CLOT IN LEFT LUNG; This spontaneous report received from a consumer concerned a female of unspecified age (in late 40's or early 50's) and ethnicity unspecified. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was diagnosed with blood clot in her left lung after receiving the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This female patient of unspecified ethnicity, in her late 40's or realy 50's, was reported to have blood clot in h er lungs after an unspecified duration from receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection.  No other details was reported.  Based on the information that is available, the event is assessed as indeterminate with the causal association to immunization, per WHO causality classification of adverse events following immunization based on a lack of a definitive plausible biological mechanism.  However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded.  Additional information will be requested once contact information is obtained
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Pain, Platelet count, Presyncope, Pulmonary thrombosis
Clinical narrative: BLOOD CLOT IN LEFT LUNG; This spontaneous report received from a consumer concerned a female of unspecified age (in late 40's or early 50's) and ethnicity unspecified. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was diagnosed with blood clot in her left lung after receiving the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This female patient of unspecified ethnicity, in her late 40's or realy 50's, was reported to have blood clot in h er lungs after an unspecified duration from receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection.  No other details was reported.  Based on the information that is available, the event is assessed as indeterminate with the causal association to immunization, per WHO causality classification of adverse events following immunization based on a lack of a definitive plausible biological mechanism.  However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded.  Additional information will be requested once contact information is obtained
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tachycardia, Ultrasound scan
Clinical narrative: BLOOD CLOT IN LEFT LUNG; This spontaneous report received from a consumer concerned a female of unspecified age (in late 40's or early 50's) and ethnicity unspecified. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was diagnosed with blood clot in her left lung after receiving the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This female patient of unspecified ethnicity, in her late 40's or realy 50's, was reported to have blood clot in h er lungs after an unspecified duration from receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection.  No other details was reported.  Based on the information that is available, the event is assessed as indeterminate with the causal association to immunization, per WHO causality classification of adverse events following immunization based on a lack of a definitive plausible biological mechanism.  However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded.  Additional information will be requested once contact information is obtained